Spencer C Evans1, Michael C Roberts2, Jared W Keeley3, Tahilia J Rebello4,5, Francisco de la Peña6, John E Lochman7, Jeffrey D Burke8, Paula J Fite2, Lourdes Ezpeleta9, Walter Matthys10, Eric A Youngstrom11, Chihiro Matsumoto12, Howard F Andrews13, María Elena Medina-Mora6, José L Ayuso-Mateos14, Brigitte Khoury15, Mayya Kulygina16, Rebeca Robles6, Pratap Sharan17, Min Zhao18, Geoffrey M Reed4,19. 1. Department of Psychology, Harvard University, Cambridge, MA, USA. 2. Clinical Child Psychology Program, University of Kansas, Lawrence, KS, USA. 3. Department of Psychology, Virginia Commonwealth University, Richmond, VA, USA. 4. Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA. 5. Behavioral Health Services and Policy Research, Research Foundation for Mental Hygiene, New York, NY, USA. 6. National Institute of Psychiatry Ramon de la Fuente Muñiz, Mexico City, Mexico. 7. Department of Psychology, University of Alabama, Tuscaloosa, AL, USA. 8. Department of Psychological Sciences, University of Connecticut, Storrs, CT, USA. 9. Research Group Epidemiology and Diagnosis in Developmental Psychopathology, Autonomous University of Barcelona, Barcelona, Spain. 10. Department of Child and Adolescent Studies, Utrecht University, Utrecht, The Netherlands. 11. Department of Psychology, University of North Carolina, Chapel Hill, NC, USA. 12. Japanese Society of Psychiatry and Neurology, Tokyo, Japan. 13. Columbia University Medical Center, New York, NY, USA. 14. Department of Psychiatry, Autonomous University of Madrid, Madrid, Spain. 15. Department of Psychiatry, American University of Beirut Medical Center, Beirut, Lebanon. 16. Alekseev Mental Health Clinic No. 1, Moscow, Russia. 17. Department of Psychiatry, ll India Institute of Medical Sciences, New Delhi, India. 18. Shanghai Jiao Tong University School of Medicine, Shanghai, China. 19. Department of Mental Health and Substance Abuse, World Health Organization, Geneva, Switzerland.
Abstract
BACKGROUND: Severe irritability has become an important topic in child and adolescent mental health. Based on the available evidence and on public health considerations, WHO classified chronic irritability within oppositional defiant disorder (ODD) in ICD-11, a solution markedly different from DSM-5's (i.e. the new childhood mood diagnosis, disruptive mood dysregulation disorder [DMDD]) and from ICD-10's (i.e. ODD as one of several conduct disorders without attention to irritability). In this study, we tested the accuracy with which a global, multilingual, multidisciplinary sample of clinicians were able to use the ICD-11 classification of chronic irritability and oppositionality as compared to the ICD-10 and DSM-5 approaches. METHODS: Clinicians (N = 196) from 48 countries participated in an Internet-based field study in English, Spanish, or Japanese and were randomized to review and use one of the three diagnostic systems. Through experimental manipulation of validated clinical vignettes, we evaluated how well clinicians in each condition could identify chronic irritability versus nonirritable oppositionality, episodic bipolar disorder, dysthymic depression, and normative irritability. RESULTS: Compared to ICD-10 and DSM-5, ICD-11 led to more accurate identification of severe irritability and better differentiation from boundary presentations. Participants using DSM-5 largely failed to apply the DMDD diagnosis when it was appropriate, and they more often applied psychopathological diagnoses to developmentally normative irritability. CONCLUSIONS: The formulation of irritability and oppositionality put forth in ICD-11 shows evidence of clinical utility, supporting accurate diagnosis. Global mental health clinicians can readily identify ODD both with and without chronic irritability.
BACKGROUND: Severe irritability has become an important topic in child and adolescent mental health. Based on the available evidence and on public health considerations, WHO classified chronic irritability within oppositional defiant disorder (ODD) in ICD-11, a solution markedly different from DSM-5's (i.e. the new childhood mood diagnosis, disruptive mood dysregulation disorder [DMDD]) and from ICD-10's (i.e. ODD as one of several conduct disorders without attention to irritability). In this study, we tested the accuracy with which a global, multilingual, multidisciplinary sample of clinicians were able to use the ICD-11 classification of chronic irritability and oppositionality as compared to the ICD-10 and DSM-5 approaches. METHODS: Clinicians (N = 196) from 48 countries participated in an Internet-based field study in English, Spanish, or Japanese and were randomized to review and use one of the three diagnostic systems. Through experimental manipulation of validated clinical vignettes, we evaluated how well clinicians in each condition could identify chronic irritability versus nonirritable oppositionality, episodic bipolar disorder, dysthymic depression, and normative irritability. RESULTS: Compared to ICD-10 and DSM-5, ICD-11 led to more accurate identification of severe irritability and better differentiation from boundary presentations. Participants using DSM-5 largely failed to apply the DMDD diagnosis when it was appropriate, and they more often applied psychopathological diagnoses to developmentally normative irritability. CONCLUSIONS: The formulation of irritability and oppositionality put forth in ICD-11 shows evidence of clinical utility, supporting accurate diagnosis. Global mental health clinicians can readily identify ODD both with and without chronic irritability.
Authors: Geoffrey M Reed; Tahilia J Rebello; Kathleen M Pike; Maria Elena Medina-Mora; Oye Gureje; Min Zhao; Yunfei Dai; Michael C Roberts; Toshimasa Maruta; Chihiro Matsumoto; Valery N Krasnov; Maya Kulygina; Anne M Lovell; Anne-Claire Stona; Pratap Sharan; Rebeca Robles; Wolfgang Gaebel; Jürgen Zielasek; Brigitte Khoury; Jair de Jesus Mari; José Luís Ayuso-Mateos; Spencer C Evans; Cary S Kogan; Shekhar Saxena Journal: Lancet Psychiatry Date: 2015-04-28 Impact factor: 27.083
Authors: David A Axelson; Boris Birmaher; Robert L Findling; Mary A Fristad; Robert A Kowatch; Eric A Youngstrom; Eugene L Arnold; Benjamin I Goldstein; Tina R Goldstein; Kiki D Chang; Melissa P Delbello; Neal D Ryan; Rasim S Diler Journal: J Clin Psychiatry Date: 2011-05-03 Impact factor: 4.384
Authors: Spencer C Evans; John R Weisz; Ana C Carvalho; Patricia M Garibaldi; Sarah Kate Bearman; Bruce F Chorpita Journal: J Consult Clin Psychol Date: 2020-03
Authors: Andrew J Freeman; Eric A Youngstrom; Jennifer K Youngstrom; Robert L Findling Journal: J Child Adolesc Psychopharmacol Date: 2016-01-08 Impact factor: 2.576
Authors: John E Lochman; Spencer C Evans; Jeffrey D Burke; Michael C Roberts; Paula J Fite; Geoffrey M Reed; Francisco R de la Peña; Walter Matthys; Lourdes Ezpeleta; Salma Siddiqui; M Elena Garralda Journal: World Psychiatry Date: 2015-02 Impact factor: 49.548
Authors: Spencer C Evans; Michael C Roberts; Jared W Keeley; Jennifer B Blossom; Christina M Amaro; Andrea M Garcia; Cathleen Odar Stough; Kimberly S Canter; Rebeca Robles; Geoffrey M Reed Journal: Int J Clin Health Psychol Date: 2015-01-29
Authors: Michael B First; Wolfgang Gaebel; Mario Maj; Dan J Stein; Cary S Kogan; John B Saunders; Vladimir B Poznyak; Oye Gureje; Roberto Lewis-Fernández; Andreas Maercker; Chris R Brewin; Marylene Cloitre; Angelica Claudino; Kathleen M Pike; Gillian Baird; David Skuse; Richard B Krueger; Peer Briken; Jeffrey D Burke; John E Lochman; Spencer C Evans; Douglas W Woods; Geoffrey M Reed Journal: World Psychiatry Date: 2021-02 Impact factor: 49.548